Puma Biotechnology (PBYI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 31,726 | 55,616 | 56,753 | 63,030 | 69,219 |
| Marketable Securities | 67,893 | 40,863 | 41,362 | 30,137 | 31,746 |
| Receivables | 53,654 | 33,565 | 25,910 | 25,172 | 32,011 |
| Inventories | 5,515 | 9,476 | 8,591 | 8,751 | 8,724 |
| Other current assets | 256 | 230 | 73 | 98 | 91 |
| TOTAL | $162,686 | $143,580 | $136,578 | $132,510 | $147,658 |
| Non-Current Assets | |||||
| PPE Net | 187 | 305 | 388 | 474 | 515 |
| Intangibles | 41,392 | 43,827 | 46,262 | 48,697 | 51,131 |
| Other Non-Current Assets | 12,037 | 15,150 | 11,688 | 14,500 | 14,029 |
| TOTAL | $53,616 | $59,282 | $58,338 | $63,671 | $65,675 |
| Total Assets | $216,302 | $202,862 | $194,916 | $196,181 | $213,333 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 22,523 | 33,716 | 33,997 | 45,329 | 45,329 |
| Accounts payable and accrued liabilities | 5,056 | 6,386 | 5,424 | 6,026 | 5,509 |
| Accrued Expenses | 50,031 | 37,116 | 31,797 | 26,873 | 36,898 |
| Other current liabilities | 2,329 | 3,040 | 3,517 | 2,697 | 2,835 |
| TOTAL | $81,253 | $82,728 | $79,099 | $86,663 | $96,111 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 10,869 | 10,647 | 21,719 |
| Other Non-Current Liabilities | 4,709 | 4,866 | 230 | 1,763 | 3,378 |
| TOTAL | $4,709 | $4,866 | $11,099 | $12,410 | $25,097 |
| Total Liabilities | $85,962 | $87,594 | $90,198 | $99,073 | $121,208 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 50,876 | 50,391 | 50,371 | 49,638 | 49,611 |
| Common Shares | 5 | 5 | 5 | 5 | 5 |
| Retained earnings | -1,283,775 | -1,297,213 | -1,306,057 | -1,311,912 | -1,314,886 |
| Other shareholders' equity | 36 | 19 | -14 | -11 | 6 |
| TOTAL | $130,340 | $115,268 | $104,718 | $97,108 | $92,125 |
| Total Liabilities And Equity | $216,302 | $202,862 | $194,916 | $196,181 | $213,333 |